A novel small compound accelerates dermal wound healing by modifying infiltration, proliferation and migration of distinct cellular components in mice

Journal of Dermatological Science

Volumn 74, Issue 3, 2014, Pages 204-213

  Yamaoka, Hanako ^a,b   Sumiyoshi, Hideaki ^a,b,c   Higashi, Kiyoshi ^d   Nakao, Sachie ^a,b,c   Minakawa, Kaori ^a,c   Sumida, Kayo ^d   Saito, Koichi ^d   Ikoma, Norihiro ^a   Mabuchi, Tomotaka ^a   Ozawa, Akira ^a   Inagaki, Yutaka ^a,b,c,e  

^a TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b TOKAI UNIVERSITY   (Japan)

^c TOKAI UNIVERSITY   (Japan)

^d SUMITOMO CHEMICAL CO LTD   (Japan)

^e JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

Artificial dermis graft; EGFP; GAPDH; H E; IFN ; IFN ; Pirin; RT PCR; SiRNA; TGF ; TGF Smad3 signal; Wound healing

Indexed keywords

ANTIFIBROTIC AGENT; HSC025; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; ALKADIENE; ALPHA 2(I) COLLAGEN; CARRIER PROTEIN; COLLAGEN TYPE 1; NUCLEAR PROTEIN; PIR PROTEIN, HUMAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DNA MICROARRAY; FEMALE; FIBROBLAST; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IN VITRO STUDY; IN VIVO STUDY; KERATINOCYTE; MACROPHAGE MIGRATION; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SKIN GRAFT; SKIN INJURY; WOUND CLOSURE; WOUND HEALING; ANIMAL; CELL CULTURE; CELL MOTION; CYTOLOGY; DRUG EFFECTS; DRUG SCREENING; GENETICS; GRANULATION TISSUE; METABOLISM; SKIN ULCER;

ALKADIENES; ANIMALS; CARRIER PROTEINS; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; COLLAGEN TYPE I; DRUG EVALUATION, PRECLINICAL; FEMALE; FIBROBLASTS; GRANULATION TISSUE; HUMANS; KERATINOCYTES; MICE; NUCLEAR PROTEINS; SKIN ULCER; TRANSFORMING GROWTH FACTOR BETA; WOUND HEALING;

EID: 84899986834     PISSN: 09231811     EISSN: 1873569X     Source Type: Journal    
DOI: 10.1016/j.jdermsci.2014.03.002     Document Type: Article

References (28)

1. Wicke C., Bachinger A., Coerper S., Beckert S., Witte M., Konigstrainer A. Aging influences wound healing in patients with chronic lower extremity wounds treated in a specialized wound care center. Wound Repair Regen 2009, 17:25-33.
2. Thomas D.R. Age-related changes in wound healing. Drugs Aging 2001, 18:607-620.
3. Mustoe T. Understanding chronic wounds: a unifying hypothesis on their pathogenesis and implications for therapy. Am J Surg 2004, 187(Supp. 1):65S-70S.
4. Barrientos S., Stojadinovic O., Golinko M.S., Blem H., Tomic-Canic M. Growth factors and cytokines in wound healing. Wound Repair Regen 2008, 16:585-601.
5. Sephel G.C., Woodward S.C. Repair, regeneration, and fibrosis. Rubin's pathology: clinicopathologic foundations of medicine 2012, 71-98. Lippincott Williams & Wilkins, Philadelphia, PA. 6th ed. S. Rhyner (Ed.).
6. Ashcroft G.S., Yang X., Glick A.B., Weinstein M., Letterio J.J., Mizel D.E., et al. Mice lacking Smad3 show accelerated wound healing and an impaired local inflammatory response. Nat Cell Biol 1999, 1:260-266.
7. Higashiyama R., Nakao S., Shibusawa Y., Ishikawa O., Moro T., Mikami K., et al. Differential contribution of dermal resident and bone marrow-derived cells to collagen production during wound healing and fibrogenesis in mice. J Invest Dermatol 2011, 131:529-536.
8. Inagaki Y., Okazaki I. Emerging insights into transforming growth factor-β Smad signal in hepatic fibrogenesis. Gut 2007, 56:284-292.
9. Higashi K., Inagaki Y., Suzuki N., Mitsui S., Mauviel A., Kaneko H., et al. Y-box binding protein YB-1 mediates transcriptional repression of human α2(I) collagen gene expression by interferon-γ. J Biol Chem 2003, 278:5156-5162.
10. Higashi K., Inagaki Y., Fujimori K., Nakao A., Kaneko A., Nakatsuka I. Interferon-γ interferes with transforming growth factor-β signaling through direct interaction of YB-1 with Smad3. J Biol Chem 2003, 278:43470-43479.
11. Inagaki Y., Kushida M., Higashi K., Itoh J., Higashiyama R., Hong Y.Y., et al. Cell type-specific intervention of TGF-β/Smad signaling suppresses collagen gene expression and hepatic fibrosis in mice. Gastroenterology 2005, 129:259-268.
12. Hasegawa M., Matsushita Y., Horikawa M., Higashi K., Tomigahara Y., Kaneko H., et al. A novel inhibitor of Smad-dependent transcriptional activation suppresses tissue fibrosis in mouse models of systemic sclerosis. Arthritis Rheum 2009, 60:3465-3475.
13. Higashi K., Tomigahara Y., Shiraki H., Miyata K., Mikami T., Kimura T., et al. A novel small compound that promotes nuclear translocation of YB-1 ameliorates experimental hepatic fibrosis in mice. J Biol Chem 2011, 286:4485-4492.
14. Inagaki Y., Truter S., Ramirez F. Transforming growth factor-β stimulates α2(I) collagen gene expression through a cis-acting element that contains an Sp1-binding site. J Biol Chem 1994, 269:14828-14834.
15. Higashi K., Hasegawa M., Yokoyama C., Tachibana T., Mitsui S., Saito K. Dermokine-β impairs ERK signaling through direct binding to GRP78. FEBS Lett 2012, 586:2300-2305.
16. Bou-Gharios G., Garrett L.A., Rossert J., Neiderreither K., Eberspaecher H., Smith C., et al. A potent far-upstream enhancer in the mouse pro alpha 2(I) collagen gene regulates expression of reporter genes in transgenic mice. J Cell Biol 1996, 134:1333-1344.
17. Higashiyama R., Moro T., Nakao S., Mikami K., Fukumitsu H., Ueda Y., et al. Negligible contribution of bone marrow-derived cells to collagen production during hepatic fibrogenesis in mice. Gastroenterology 2009, 137(4):1459-1466.
18. Inagaki Y., Truter S., Bou-Gharios G., Garrett L.A., de Crombrugghe B., Nemoto T., et al. Activation of proα2(I) collagen promoter during hepatic fibrogenesis in transgenic mice. Biochem Biophys Res Commun 1998, 250:606-611.
19. Koide M., Osaki K., Konishi J., Oyamada K., Katakura T., Takahashi A., et al. A new type of biomaterial for artificial skin: dehydrothermally cross-linked composites of fibrillar and denatured collagens. J Biomed Mater Res 1993, 27:79-87.
20. Higashiyama R., Inagaki Y., Hong Y.Y., Kushida M., Nakao S., Niioka M., et al. Bone marrow-derived cells express matrix metalloproteinases and contribute to regression of liver fibrosis in mice. Hepatology 2007, 45:213-222.
21. Shipley G.D., Pittelkow M.R., Wille J.J., Scott R.E., Moses H.L. Reversible inhibition of normal human prokeratinocyte proliferation by type β transforming growth factor-growth inhibitor in serum-free medium. Cancer Res 1986, 46:2068-2071.
22. Wendler W.M.F., Kremmer E., Forster R., Winnacker E.L. Identification of pirin, a novel highly conserved nuclear protein. J Biol Chem 1997, 272:8482-8489.
23. Miyazaki I., Simizu S., Okumura H., Takagi S., Osada H. A small-molecule inhibitor shows that pirin regulates migration of melanoma cells. Nat Chem Biol 2010, 6:667-673.
24. Savagner P., Kusewitt D.F., Carver E.A., Magnino F., Choi C., Gridley T., et al. Developmental transcription factor Slug is required for effective re-epithelialization by adult keratinocytes. J Cell Physiol 2005, 202:858-866.
25. Arnoux V., Nassour M., L'Helgoualc'h A., Hipskind R.A., Savanger P. Erk5 controls Slug expression and keratinocyte activation during wound healing. Mol Biol Cell 2008, 19:4738-4749.
26. 1,2 reduces cutaneous scarring in adult rodents. J Cell Sci 1994, 107:1137-1157.
27. Huang J.S., Wang Y.H., Ling T.Y., Chuang S.S., Johnson F.E., Huang S.S. Synthetic TGF-β antagonist accelerates wound healing and reduces scarring. FASEB J 2002, 16:1269-1270.
28. Yang C.C., Lin S.D., Yu H.S. Effect of growth factors on dermal fibroblast contraction in normal skin and hypertrophic scar. J Dermatol Sci 1997, 14:162-169.